41 – 50 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
The prognostic value of BVAS and VDI in ANCA-AAV
2011) 15th International Vasculitis/ANCA Workshop In Clinical and Experimental Immunology 164(Suppl. 1). p.121-121(
- Contribution to journal › Published meeting abstract
-
Mark
A Model to Predict Cardiovascular Events in Patients With Newly Diagnosed Wegener's Granulomatosis and Microscopic Polyangiitis
(
- Contribution to journal › Article
-
Mark
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
(
- Contribution to journal › Article
-
Mark
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
(
- Contribution to journal › Article
- 2010
-
Mark
A Model To Predict Cardiovascular Events In Patients With Newly Diagnosed Wegener'S Granulmoatosis And Microscopic Polyangiitis
2010) Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British-Health-Professional-in-Rheumatology In Rheumatology 49. p.124-124(
- Contribution to journal › Published meeting abstract
-
Mark
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
(
- Contribution to journal › Article
- 2009
-
Mark
EULAR recommendations for the management of primary small and medium vessel vasculitis
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of large vessel vasculitis
(
- Contribution to journal › Article
-
Mark
The association between relapses of ANCA-associated vasculitis and the composite endpoint of end-stage renal disease or death
(
- Contribution to journal › Published meeting abstract
-
Mark
Predictors of long-term (>= 5 year) renal survival in 535 patients with ANCA-associated vasculitis
(
- Contribution to journal › Published meeting abstract